Table 2

Univariate survival analysis of biochemical recurrence (BCR)-free survival in 128 patients with PCa
Variables BCR-free survival
Exp (B) 95% CI P
Age (<70 vs. ≥70) 2.68 0.17–5.03 NS
Preoperative PSA (<10 ng/mL vs. ≥10 ng/mL) 2.34 0.11–4.48 NS
Gleason score (4–6 vs. 7–10) 2.26 0.10–4.32 NS
Pathological stage (T1-2 vs. T3-4) 5.61 1.12–11.28 <0.001
Lymph node metastasis (Negative vs. Positive) 4.13 0.82–8.22 0.002
Angiolymphatic invasion (Negative vs. Positive) 5.62 1.12–11.39 <0.001
Surgical margin status (Negative vs. Positive) 2.27 0.10–4.82 NS
miR-126 expression (High vs. Low) 5.68 1.19–11.33 <0.001

Note: ‘NS’ refers to the difference without statistic significance.

Sun et al.

Sun et al. Diagnostic Pathology 2013 8:208   doi:10.1186/1746-1596-8-208

Open Data